Propylthiouracil-induced hepatic damage
Annals of Pharmacotherapy, cilt.30, sa.9, ss.960-963, 1996 (Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 30 Sayı: 9
- Basım Tarihi: 1996
- Doi Numarası: 10.1177/106002809603000909
- Dergi Adı: Annals of Pharmacotherapy
- Derginin Tarandığı İndeksler: Scopus
- Sayfa Sayıları: ss.960-963
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
OBJECTION: To report a case of propylthiouracil-induced hepatic damage. CASE SUMMARY: A 64- year-old white woman with hyperthyroidism received propylthiouracil 250 mg/d for 1 year. She developed hepatitis after 1 year of therapy. Alcohol and drug abuse were ruled out and all serologic tests for hepatitis A, B, and C were negative. Cytomegalovirus and Epstein-Barr virus infection were also ruled out. Antinuclear antibody, antimitochondrial antibody, and antismooth muscle antibody were negative. The clinical picture was similar to that of vital hepatitis characterized by nausea, vomiting, and jaundice. Histologic examination of a liver biopsy specimen showed chronic active hepatitis. The patient developed cirrhosis during follow-up. DISCUSSION: Propylthiouracil is widely used in the treatment of hyperthyroidism. Despite its widespread use, there have been only a few reported cases of propylthiouracil-induced hepatotoxicity. The precise mechanism of the injury is unknown, although immunologic factors are suggested. CONCLUSIONS: Hepatic damage induced by propylthiouracil is a rare complication. However, the danger of permanent hepatic damage should be kept in mind. The best way of preventing propylthiouracil hepatotoxicity is careful screening of patients considered for treatment.